Chapter 4.10 Acetylcholinesterase as a window onto stress responses

Techniques in the Behavioral and Neural Sciences

Volumn 15, Issue PART 1, 2005, Pages 585-608

  Soreq, Hermona ^a   Yirmiya, Raz ^a   Cohen, Osnat ^a   Glick, David ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66549119033     PISSN: 09210709     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0921-0709(05)80032-X     Document Type: Chapter

References (193)

1. ++ -dependent protein kinase (PKC) activity and intracellular translocation (Young et al., 2002). V. Abou-Donia M.B., Goldstein L.B., Jones K.H., Abdel-Rahman A.A., Damodaran T., Dechkovskaia A.M., Bullman S.L., Amir B.E., Khan W.A. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. Toxicol Sci 60 (2001) 305-314
2. Abou-Donia M.B., Wilmarth K.R., Jensen K.F., Oehme F.W., and Kurt T.L. Neurotoxicity resulting from coexposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures. J. Toxicol. Environ. Health 48 (1996) 35-56
3. Acquas E., Wilson C., and Fibiger H.C. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J. Neurosci. 16 (1996) 3089-3096
4. Andres C., Beeri R., Friedman A., Lev-Lehman E., Henis S., Timberg R., Shani M., and Soreq H. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Iβ gene expression followed by late-onset neuromotor deterioration. Proc. Natl. Acad. Sci. USA 94 (1997) 8173-8178
5. Appleyard M.E. Secreted acetylcholinesterase: nonclassical aspects of a classical enzyme. Trends Neurosci. 15 (1992) 485-490
6. (Honolulu). Argov Z., McKee D., Agus S., Soreq H., Ben-Yoseph O., Brawer S., and Sussman J. EN101: a novel antisense therapeutic strategy for myasthenia gravis. Paper presented at: Fifty-fifth Annual Meeting of the American Academy of Neurology (2003)
7. Ashani Y., Shapira S., Levy D., Wolfe A.D., Doctor B.P., and Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 41 (1991) 37-41
8. Atanasova E., Chiappa S., Wieben E., and Brimijoin S. Novel messenger RNA and alternative promoter for murine acetylcholinesterase. J. Biol. Chem. 274 (1999) 21078-21084
9. Bartels M., de Geus E.J., Kirschbaum C., Sluyter F., and Boomsma D.I. Heritability of daytime cortisol levels in children. Behav. Genet. 33 (2003) 421-433
10. Bartus R.T., Dean III R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-414
11. Battaglia M. Beyond the usual suspects: a cholinergic route for panic attacks. Mol Psychiatry 7 (2002) 239-246
12. Battaini F., Pascale A., Lucchi L., Pasinetti G.M., and Govoni S. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. Exp. Neurol. 159 (1999) 559-564
13. Beck K.D., Zhu G., Beldowicz D., Brennan F.X., Ottenweller J.E., Moldow R.L., and Servatius R.J. Central nervous system effects from a peripherally acting cholinesterase inhibiting agent: interaction with stress or genetics. Ann. N. Y. Acad. Sci. 933 (2001) 310-314
14. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M., and Soreq H. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5 (1995) 1063-1071
15. Beeri R., Le Novere N., Mervis R., Huberman T., Grauer E., Changeux J.P., and Soreq H. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69 (1997) 2441-2451
16. Bernatova I., Key M.P., Lucot J.B., and Morris M. Circadian differences in stress-induced pressor reactivity in mice. Hypertension 40 (2002) 768-773
17. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Ulloa L., Yang H., Sudan S., Czura C.J., Ivanova S.M., and Tracey K.J. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195 (2002) 781-788
18. Berrouschot J., Baumann I., Kalischewski P., Sterker M., and Schneider D. Therapy of myasthenic crisis. Crit. Care Med. 25 (1997) 1228-1235
19. Bhatnagar S., Costall B., and Smythe J.W. Hippocampal cholinergic blockade enhances hypothalamic-pituitary-adrenal responses to stress. Brain Res. 766 (1997) 244-248
20. Bigbee J.W., Sharma K.V., Gupta J.J., and Dupree J.L. Morphogenic role for acetylcholinesterase in axonal outgrowth during neural development. Environ. Health Perspect. 107 Suppl 1 (1999) 81-87
21. Birikh K., Sklan E., Shoham S., and Soreq H. Interaction of "readthrough" acetylcholinesterase with RACK1 and PKCbetaII correlates with intensified fear-induced conflict behavior. Proc. Natl. Acad. Sci. USA 100 (2003) 283-288
22. Blanchet G., Carpentier P., Lallement G., and Sentenac-Roumanou H. Prevention and treatment of status epilepticus induced by soman. Ann. Pharm. Fr. 52 (1994) 11-24
23. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., and Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
24. Botti S.A., Felder C.E., Sussman J.L., and Silman I. Electrotactins: a class of adhesion proteins with conserved electrostatic and structural motifs. Protein Eng. 11 (1998) 415-420
25. Bremner J.D., Vythilingam M., Anderson G., Vermetten E., McGlashan T., Heninger G., Rasmusson A., Southwick S.M., and Charney D.S. Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder. Biol. Psychiatry 54 (2003) 710-718
26. Brenner T., Hamra-Amitay Y., Evron T., Boneva N., Seidman S., and Soreq H. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. FASEB J. 17 (2003) 214-222
27. Brindle N., Song Y., Rogaeva E., Premkumar S., Levesque G., Yu G., Ikeda M., Nishimura M., Paterson A., Sorbi S., et al. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease. Hum. Mol. Genet. 7 (1998) 933-935
28. Brooke S.M., and Sapolsky R.M. Glucocorticoid Exacerbation of gp120 Neurotoxicity: Role of Microglia. Exp. Neurol. 177 (2002) 151-158
29. Burchfiel J.L., and Duffy F.H. Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav. Toxicol. Teratol. 4 (1982) 767-778
30. Calogero A.E., Gallucci W.T., Bernardini R., Saoutis C., Gold P.W., and Chrousos G.P. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinology 47 (1988) 303-308
31. Calogero A.E., Kamilaris T.C., Gomez M.T., Johnson E.O., Tartaglia M.E., Gold P.W., and Chrousos G.P. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Endocrinology 125 (1989) 2445-2453
32. Camp S., and Taylor P. Intronic elements appear essential for the differentiation-specific expression of acetylcholinesterase in C2C12 myotubes. In: Doctor B.P., Taylor P., Quinn D.M., Rotundo R.L., and Gentry M.K. (Eds). Structure and Function of Cholinesterases and Related Proteins (1998), Plenum Press, Berlin 51-55
33. Carlson N.R. Physiology of Behavior, Allyn and Bacon (1994), Needham Heights, New York
34. Carmichael W. The toxins of cyanobacteria. Sci. Amer. 270 (1994) 78-86
35. Chan R.Y., Adatia F.A., Krupa A.M., and Jasmin B.J. Increased expression of acetylcholinesterase T and R transcripts during hematopoietic differentiation is accompanied by parallel elevations in the levels of their respective molecular forms. J. Biol. Chem. 273 (1998) 9727-9733
36. Chaney L.A., Rockhold R.W., Wineman R.W., and Hume A.S. Anticonvulsant-resistant seizures following pyridostigmine bromide (PB) and N,N-diethyl-m-toluamide (DEET) Toxicol. Sci. 49 (1999) 306-311
37. Chaney L.A., Wineman R.W., Rockhold R.W., and Hume A.S. Acute effects of an insect repellent, N,N-diethyl-m-toluamide, on cholinesterase inhibition induced by pyridostigmine bromide in rats. Toxicol. Appl. Pharmacol. 165 (2000) 107-114
38. Chen Y., Brunson K.L., Muller M.B., Cariaga W., and Baram T.Z. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J. Comp. Neurol. 420 (2000) 305-323
39. Cohen O., Erb C., Ginzberg D., Pollak Y., Seidman S., Shoham S., Yirmiya R., and Soreq H. Neuronal overexpression of 'readthrough' acetylcholinesterase is associated with antisense-suppressible behavioral impairments. Mol. Psychiatry 7 (2002) 874-885
40. Cohen O., Reichenberg A., Perry C., Ginzberg D., Pollmächer T., Soreq H., and Yirmiya R. Endotoxin-induced changes in human working and declarative memory are associated with C - terminal cleavage of plasma "readthrough" acetylcholinesterase. J. Molec. Neurosci. 21 (2003) 199-212
41. Cook W.O., Beasley V.R., Dahlem A.M., Dellinger J.A., Harlin K.S., and Carmichael W.W. Comparison of effects of anatoxin-a(s) and paraoxon, physostigmine and pyridostigmine on mouse brain cholinesterase activity. Toxicon. 26 (1988) 750-753
42. Dantzer R., Tazi A., and Bluthe R.M. Cerebral lateralization of olfactory-mediated affective processes in rats. Behav. Brain Res. 40 (1990) 53-60
43. Danzer R., Whollman E.E., and Yirmiya R. Cytokines, Stress and Depression (1999), Kluwer Academic/Plenum, MA
44. Daoud R., Da Penha Berzaghi M., Siedler F., Hubener M., and Stamm S. Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur. J. Neurosci. 11 (1999) 788-802
45. Darboux I., Barthalay Y., Piovant M., and Hipeau Jacquotte R. The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties. EMBO J. 15 (1996) 4835-4843
46. Darreh-Shori T., Almkvist O., Guan Z.Z., Garlind A., Strandberg B., Svensson A.L., Soreq H., Hellstrom-Lindahl E., and Nordberg A. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology 59 (2002) 563-572
47. Darreh-Shori T., Hellström-Lindahl E., Flores-Flores C., Guan Z., Soreq H., and Nordberg A. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. J. Neurochem. 88 (2004) 1102-1113
48. Day J.C., Koehl M., Deroche V., Le Moal M., and Maccari S. Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release in adult rats. J. Neurosci. 18 (1998) 1886-1892
49. Day J.C., Koehl M., Le Moal M., and Maccari S. Corticotropin-releasing factor administered centrally, but not peripherally, stimulates hippocampal acetylcholine release. J. Neurochem. 71 (1998) 622-629
50. Dazzi L., Motzo C., Imperato A., Serra M., Gessa G.L., and Biggio G. Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators. J. Pharmacol. Exp. Ther. 273 (1995) 241-247
51. de Quervain D.J., Roozendaal B., Nitsch R.M., McGaugh J.L., and Hock C. Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat. Neurosci. 3 (2000) 313-314
52. Deutsch V.R., Pick M., Perry C., Grisaru D., Hemo Y., Golan-Hadari D., Grant A., Eldor A., and Soreq H. The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. Exp. Hematol. 30 (2002) 1153-1161
53. Doctor B.P., Blick D.W., Caranto G., Castro C.A., Gentry M.K., Larrison R., Maxwell D.M., Murphy M.R., Schutz M., Waibel K., et al. Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity. Chem. Biol. Interact 87 (1993) 285-293
54. Drachman D.A., and Leavitt J. Human memory and the cholinergic system. A relationship to aging?. Arch. Neurol. 30 (1974) 113-121
55. Ellis K.A., and Nathan P.J. The pharmacology of human working memory. Int. J. Neuropsychopharmacol. 4 (2001) 299-313
56. Erb C., Troost J., Kopf S., Schmitt U., Loffelholz K., Soreq H., and Klein J. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. 77 (2001) 638-646
57. Esposito P., Chandler N., Kandere K., Basu S., Jacobson S., Connolly R., Tutor D., and Theoharides T.C. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther. 303 (2002) 1061-1066
58. Esposito P., Gheorghe D., Kandere K., Pang X., Connolly R., Jacobson S., and Theoharides T.C. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888 (2001) 117-127
59. Evans W.E., and Relling M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286 (1999) 487-491
60. Farchi N., Soreq H., and Hochner B. Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology. J. Physiol. 546 (2003) 165-173
61. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci. 14 (1991) 220-223
62. Finkelstein Y., Koffler B., Rabey J.M., and Gilad G.M. Dynamics of cholinergic synaptic mechanisms in rat hippocampus after stress. Brain Res. 343 (1985) 314-319
63. Friedman A., Kaufer D., Pavlovsky L., and Soreq H. Cholinergic excitation induces activity-dependent electrophysiological and transcriptional responses in hippocampal slices. J. Physiol. Paris 92 (1998) 329-335
64. Friedman A., Kaufer D., Shemer J., Hendler I., Soreq H., and Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med. 2 (1996) 1382-1385
65. Friedman M. Tomato glycoalkaloids: role in the plant and in the diet. J. Agric. Food Chem. 50 (2002) 5751-5780
66. Fu Y., Matta S.G., Valentine J.D., and Sharp B.M. Adrenocorticotropin response and nicotine-induced norepinephrine secretion in the rat paraventricular nucleus are mediated through brainstem receptors. Endocrinology 138 (1997) 1935-1943
67. Fullerton C.S., and Ursano R.J. Behavioral and psychological responses to chemical and biological warfare. Mil. Med. 155 (1990) 54-59
68. Furey M.L., Pietrini P., and Haxby J.V. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290 (2000) 2315-2319
69. Galyam N., Grisaru D., Grifman M., Melamed-Book N., Eckstein F., Seidman S., Eldor A., and Soreq H. Complex host cell responses to antisense suppression of ACHE gene expression. Antisense Nucl. Acid Drug Dev. 11 (2001) 51-57
70. Giacobini E. Cholinesterase inhibitors: from the Calabar bean to Alzheimer therapy. In: Giacobini E. (Ed). Cholinesterases and Cholinesterase Inhibitors (2000), Martin Dunitz, New York 181-226
71. Giacobini E. Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer' disease. J. Neural. Transm. Suppl. 62 (2002) 181-187
72. Gilad G.M. The stress-induced response of the septo-hippocampal cholinergic system. A vectorial outcome of psychoneuroendocrinological interactions. Psychoneuroendocrinology 12 (1987) 167-184
73. Gilad G.M., Mahon B.D., Finkelstein Y., Koffler B., and Gilad V.H. Stress-induced activation of the hippocampal cholinergic system and the pituitary-adrenocortical axis. Brain Res. 347 (1985) 404-408
74. Golomb B. A Review of the Scientific Literature as it Pertains to Gulf War Illnesses Vol 2 (1999), Rand Corp, Santa Monica
75. Gonzalez A.M., and Pazos A. Modification of muscarinic acetylcholine receptors in the rat brain following chronic immobilization stress: an autoradiographic study. Eur. J. Pharmacol. 223 (1992) 25-31
76. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., and Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383 (1996) 713-716
77. Greenfield S. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28 (1996) 485-490
78. Greenfield S., and Vaux D.J. Parkinson's disease, Alzheimer's disease and motor neurone disease: identifying a common mechanism. Neuroscience 113 (2002) 485-492
79. Grifman M., Galyam N., Seidman S., and Soreq H. Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis. Proc. Natl. Acad. Sci. USA 95 (1998) 13935-13940
80. Grisaru D., Deutch V., Shapira M., Galyam N., Lessing B., Eldor A., and Soreq H. ARP, a peptide derived from the stress-associated acetylcholinesterase variant, has hematopoietic growth promoting activities. Mol. Med. 7 (2001) 93-105
81. Grisaru D., Sternfeld M., Eldor A., Glick D., and Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 264 (1999) 672-686
82. Hillegaart V., and Ahlenius S. Time course for synchronization of spontaneous locomotor activity in the rat following reversal of the daylight (12:12 h) cycle. Physiol. Behav. 55 (1994) 73-75
83. Imperato A., Puglisi-Allegra S., Casolini P., and Angelucci L. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 538 (1991) 111-117
84. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., and Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur. J. Pharmacol. 165 (1989) 337-338
85. Inglis F.M., Day J.C., and Fibiger H.C. Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal. Neuroscience 62 (1994) 1049-1056
86. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34 (2003) 27-29
87. Kalow W., and Genest K. A method for detection of atypical forms of human serum cholinesterase: Determination of dibucaine numbers. Can. J. Biochem. 35 (1957) 339-346
88. Kaneto H. Learning/memory processes under stress conditions. Behav. Brain Res. 83 (1997) 71-74
89. Kant G.J., Bauman R.A., Feaster S.R., Anderson S.M., Saviolakis G.A., and Garcia G.E. The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats. Pharmacol. Biochem. Behav. 70 (2001) 209-218
90. Karpel R., Sternfeld M., Ginzberg D., Guhl E., Graessmann A., and Soreq H. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells. J. Neurochem. 66 (1996) 114-123
91. Kaufer D., Friedman A., Seidman S., and Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393 (1998) 373-377
92. Kaufer D., Friedman A., Seidman S., and Soreq H. Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission. Chem. Biol. Interact. 119-120 (1999) 349-360
93. Kaufer D., and Soreq H. Tracking cholinergic pathways from psychological and chemical stressors to variable neurodeterioration paradigms. Curr. Opin. Neurol. 12 (1999) 739-743
94. Kelsey J.E. The role of norepinephrine and acetylcholine in mediating escape deficits produced by inescapable shocks. Behav. Neural. Biol. 37 (1983) 326-331
95. Kirschbaum C., Wolf O.T., May M., Wippich W., and Hellhammer D.H. Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci. 58 (1996) 1475-1483
96. Koenigsberger C., Chiappa S., and Brimijoin S. Neurite differentiation is modulated in neuroblastoma cells engineered for altered acetylcholinesterase expression. J. Neurochem. 69 (1997) 1389-1397
97. Konsman J.P., Parnet P., and Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25 (2002) 154-159
98. Kronman C., Chitlaru T., Elhanany E., Velan B., and Shafferman A. Hierarchy of post-translation modifications involved in the circulatory longevity of glycoproteins. Demonstration of concerted contributions of glycan sialylation and subunit assembly to the pharmacokinetic behavior of acetylcholinesterase. J. Biol. Chem. 275 (2000) 29488-29502
99. La Du B.N., Bartels C.F., Nogueira C.P., Hajra A., Lightstone H., Van der Spek A., and Lockridge O. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants. Clin. Biochem. 23 (1990) 423-431
100. Layer P.G. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28 (1996) 491-495
101. Lehmann D.J., Johnston C., and Smith A.D. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum. Mol. Genet. 6 (1997) 1933-1936
102. Lehmann D.J., Nagy Z., Litchfield S., Borja M.C., and Smith A.D. Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease. Hum. Genet. 106 (2000) 447-452
103. Li Y., Liu L., Kang J., Sheng J.G., Barger S.W., Mrak R.E., and Griffin W.S. Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. J. Neurosci. 20 (2000) 149-155
104. Lightman S.L., Windle R.J., Julian M.D., Harbuz M.S., Shanks N., Wood S.A., Kershaw Y.M., and Ingram C.D. Significance of pulsatility in the HPA axis. Novartis Found Symp. 227 (2000) 244-257
105. Liu W.F. Acute effects of oral low doses of pyridostigmine on simple visual discrimination and unconditioned consummatory acts in rats. Pharmacol. Biochem. Behav. 41 (1992) 251-254
106. Llinas R.R., and Greenfield S.A. On-line visualization of dendritic release of acetylcholinesterase from mammalian substantia nigra neurons. Proc. Natl. Acad. Sci. USA 84 (1987) 3047-3050
107. Luo Z.D., Wang Y., Werlen G., Camp S., Chien K.R., and Taylor P. Calcineurin enhances acetylcholinesterase mRNA stability during C2-C12 muscle cell differentiation. Mol. Pharmacol. 56 (1999) 886-894
108. Lupien S.J., and Lepage M. Stress, memory, and the hippocampus: can't live with it, can't live without it. Behav. Brain Res. 127 (2001) 137-158
109. Lupien S.J., Maheu F., Tu M.T., Lemay M., McEwen B.S., and Meaney M.J. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev. Neurosci. 10 (1999) 117-139
110. Maes M., Song C., Lin A., De Jongh R., Van Gastel A., Kenis G., Bosmans E., De Meester I., Benoy I., Neels H., Demedts P., Janca A., Scharpe S., and Smith R.S. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10 (1998) 313-318
111. Marchot P., Prowse C.N., Kanter J., Camp S., Ackermann E.J., Radic Z., Bougis P.E., and Taylor P. Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom. J. Biol. Chem. 272 (1997) 3502-3510
112. Marx J. How the glucocorticoids suppress immunity. Science 270 (1995) 232
113. Massoulie J. Molecular forms and anchoring of acetylcholinesterase. In: Giacobini E. (Ed). Cholinesterases and Cholinesterase Inhibitors (2000), Martin Dunitz 81-101
114. Matta S.G., Singh J., and Sharp B.M. Catecholamines mediate nicotine-induced adrenocorticotropin secretion via alpha-adrenergic receptors. Endocrinology 127 (1990) 1646-1655
115. McGehee D.S., Krasowski M.D., Fung D.L., Wilson B., Gronert G.A., and Moss J. Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism. Anesthesiology 93 (2000) 510-519
116. Meshorer E., Erb C., Gazit R., Pavlovsky L., Kaufer D., Friedman A., Glick D., Ben-Arie N., and Soreq H. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295 (2002) 508-512
117. Meshorer E., and Soreq H. Pre-mRNA splicing modulations in senescence Aging Cell 1 1 (2002) 10-16
118. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., and Tabira T. Effect of chronic stress on cholinergic transmission in rat hippocampus. Brain Res. 915 (2001) 108-111
119. Mizuno T., and Kimura F. Attenuated stress response of hippocampal acetylcholine release and adrenocortical secretion in aged rats. Neurosci. Lett. 222 (1997) 49-52
120. Mor I., Grisaru D., Titelbaum L., Evron T., Richler C., Wahrman J., Sternfeld M., Yogev L., Meiri N., Seidman S., and Soreq H. Modified testicular expression of stress-associated "readthrough" acetylcholiensterase predicts male infertility. FASEB J. 15 (2001) 2039-2041
121. Munck A., and Naray-Fejes-Toth A. Glucocorticoids and stress: permissive and suppressive actions. Ann. N. Y. Acad. Sci. 746 (1994) 115-130
122. Nguyen K.T., Deak T., Owens S.M., Kohno T., Fleshner M., Watkins L.R., and Maier S.F. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J. Neurosci. 18 (1998) 2239-2246
123. Nguyen T., and Sudhof T.C. Binding properties of neuroligin 1 and neurexin 1β reveal function as heterophilic cell adhesion molecules. J Biol Chem 272 (1997) 26032-26039
124. in press. Nijholt I., Farchi N., Kye M.-J., Sklan E., Shoham S., Verbeurre B., Owen D., Hochner B., Spiess J., Soreq H., and Blank T. Alternative splicing modulation of hippocampal long-term potentiation and fear memory. Mol. Psych. (2003)
125. Nilsson L., Nordberg A., Hardy J., Wester P., and Winblad B. Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level. J. Neural. Transm. 67 (1986) 275-285
126. Ohmori N., Itoi K., Tozawa F., Sakai Y., Sakai K., Horiba N., Demura H., and Suda T. Effect of acetylcholine on cirticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Endocrinology 136 (1995) 4858-4863
127. Ohno K., Engel A.G., Brengman J.M., Shen X.M., Heidenreich F., Vincent A., Milone M., Tan E., Demirci M., Walsh P., et al. The spectrum of mutations causing end-plate acetylcholinesterase deficiency. Ann. Neurol. 47 (2000) 162-170
128. Opalinska J.B., and Gewirtz A.M. Nucleic-acid therapeutics: basic principles and recent applications. Nat. Rev. Drug Discov. 1 (2002) 503-514
129. Orr R.M. Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision. Curr. Opin. Mol. Ther. 3 (2001) 288-294
130. Orsini C., Castellano C., and Cabib S. Pharmacological evidence of muscarinic-cholinergic sensitization following chronic stress. Psychopharmacology (Berl) 155 (2001) 144-147
131. Palmer A.M. Pharmacotherapy for Alzheimer's disease: progress and prospects. Trends Pharmacol. Sci. 23 (2002) 426-433
132. Perrier A.L., Massoulie J., and Krejci E. PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33 (2002) 275-285
133. Perry C., Sklan E.H., Birikh K., Shapira M., Trejo L., Eldor A., and Soreq H. Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene 21 (2002) 8428-8441
134. Perry C., and Soreq H. Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements. Eur. J. Biochem. 269 (2002) 3607-3618
135. Perry E., Martin-Ruiz C., Lee M., Griffiths M., Johnson M., Piggott M., Haroutunian V., Buxbaum J.D., Nasland J., Davis K., Gotti C., Clementi F., Tzartos S., Cohen O., Soreq H., Jaros E., Perry R., Ballard C., McKeith I., and Court J. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur. J. Pharmacol. 393 (2000) 215-222
136. Ponting C., Phillips C., Davies K., and Blake D. PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays. 19 (1997) 469-479
137. Raveh L., Ashani Y., Levy D., De La Hoz D., Wolfe A.D., and Doctor B.P. Acetylcholinesterase prophylaxis against organophosphate poisoning. Quantitative correlation between protection and blood-enzyme level in mice. Biochem. Pharmacol. 38 (1989) 529-534
138. Rees T., Hammond P.I., Soreq H., Younkin S., and Brimijoin S. Acetylcholinesterase promotes betaamyloid plaques in cerebral cortex. Neurobiol. Aging. 24 (2003) 777-787
139. Rees T., Hammond P.I., Soreq H., Younkin S., and Brimijoin S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol. Aging 24 (2003) 777-787
140. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., and Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry. 58 (2001) 445-452
141. Relyea R.A., and Mills N. Predator-induced stress makes the pesticide carbaryl more deadly to gray treefrog tadpoles (Hyla versicolor). Proc. Natl. Acad. Sci. USA 98 (2001) 2491-2496
142. Roddick J.G. The acetylcholinesterase-inhibitory activity of steroidal glycoalkaloids and their aglycones. Phytochemistry 28 (1989) 2631-2634
143. Rosenstock L., Keifer M., Daniell W., McConnell R., and Claypoole K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. The Pesticide Health Effects Study Group. Lancet. 338 (1991) 223-227
144. Rubin L.L., and Staddon J.M. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22 (1999) 11-28
145. Ruppin E., and Reggia J.A. Patterns of functional damage in neural network models of associative memory. Neural Comput. 7 (1995) 1105-1127
146. Sago H., Carlson E.J., Smith D.J., Kilbridge J., Rubin E.M., Mobley W.C., Epstein C.J., and Huang T.T. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc. Natl. Acad. Sci. USA 95 (1998) 6256-6261
147. Sapolsky R.M. Chickens, eggs and hippocampal atrophy. Nat. Neurosci. 5 (2002) 1111-1113
148. Sauvage M., and Steckler T. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei-potential implication for arousal and attention. Neurosci. 104 (2001) 643-652
149. Scheiffele P., Fan J., Choih J., Fetter R., and Serafini T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101 (2000) 657-669
150. Schwarz M., Glick D., Loewenstein Y., and Soreq H. Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. Pharmacol. Ther. 67 (1995) 283-322
151. Servatius R.J., Ottenweller J.E., Beldowicz D., Guo W., Zhu G., and Natelson B.H. Persistently exaggerated startle responses in rats treated with pyridostigmine bromide. J. Pharmacol. Exp. Ther. 287 (1998) 1020-1028
152. Shapira M., Grant A., Korner M., and Soreq H. Genomic and transcriptional characterization of the human ACHE locus: complex involvement with acquired and inherited diseases. Isr. Med. Assoc. J. 2 (2000) 470-473
153. Shapira M., Tur-Kaspa I., Bosgraaf L., Livni N., Grant A.D., Grisaru D., Korner M., Ebstein R.P., and Soreq H. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum. Mol. Genet. 9 (2000) 1273-1281
154. Shaw N. The neurophysiology of concussion. Prog. Neurobiol. 67 (2002) 281
155. Shih T.M., and McDonough Jr. J.H. Neurochemical mechanisms in soman-induced seizures. J. Appl. Toxicol. 17 (1997) 255-264
156. Shohami E., Kaufer D., Chen Y., Seidman S., Cohen O., Ginzberg D., Melamed-Book N., Yirmiya R., and Soreq H. Antisense prevention of neuronal damages following head injury in mice. J. Mol. Med. 78 (2000) 228-236
157. Silman I., and Futerman A.H. Modes of attachment of acetylcholinesterase to the surface membrane. Eur. J. Biochem. 170 (1987) 11-22
158. Silver A. The Biology of Cholinesterases (1974), North Holland, Amsterdam
159. Small D.H., Michaelson S., and Sberna G. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. 28 (1996) 453-483
160. Somani S.M., Husain K., Asha T., and Helfert R. Interactive and delayed effects of pyridostigmine and physical stress on biochemical and histological changes in peripheral tissues of mice. J. Appl. Toxicol. 20 (2000) 327-334
161. Song J.Y., Ichtchenko K., Sudhof T.C., and Brose N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc. Natl. Acad. Sci. USA 96 (1999) 1100-1105
162. Soreq H., and Glick D. Novel roles for cholinesterases in stress and inhibitor responses. In: Giacobini E. (Ed). Cholinesterases and Cholinesterase Inhibitors: Basic, Preclinical and Clinical Aspects (2000), Martin Dunitz 47-61
163. Spivak B., Shohat B., Mester R., Avraham S., Gil-Ad I., Bleich A., Valevski A., and Weizman A. Elevated levels of serum interleukin-1 beta in combat-related post-traumatic stress disorder. Biol. Psychiatry. 42 (1997) 345-348
164. Stamm S. Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Hum. Mol. Genet. 11 (2002) 2409-2416
165. Stansbury K., Haley D., and Koeneker A. Higher cortisol values facilitate spatial memory in toddlers. Brief report. Ann. N. Y. Acad. Sci. 911 (2000) 456-458
166. Steckler T., and Holsboer F. Interaction between the cholinergic system and CRF in the modulation of spatial discrimination learning in mice. Brain Res. 906 (2001) 46-59
167. Stephens R., Spurgeon A., Calvert I.A., Beach J., Levy L.S., Berry H., and Harrington J.M. Neuropsychological effects of long-term exposure to organophosphates in sheep dip. Lancet 345 (1995) 1135-1139
168. Sternfeld M., Ming G., Song H., Sela K., Timberg R., Poo M., and Soreq H. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J. Neurosci. 18 (1998) 1240-1249
169. Sternfeld M., Patrick J.D., and Soreq H. Position effect variegations and brain-specific silencing in transgenic mice overexpressing human acetylcholinesterase variants. J. Physiol. Paris. 92 (1998) 249-255
170. Sternfeld M., Shoham S., Klein O., Flores-Flores C., Evron T., Idelson G.H., Kitsberg D., Patrick J.W., and Soreq H. Excess "readthrough" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc. Natl. Acad. Sci. USA 97 (2000) 8647-8652
171. Stillman M.J., Shukitt-Hale B., Coffey B.P., Levy A., and Lieberman H.R. In vivo hippocampal acetylcholine release during exposure to acute stress. Stress 1 (1997) 191-200
172. Stitcher D.L., Harris L.W., Heyl W.C., and Alter S.C. Effects of pyridostigmine and cholinolytics on cholinesterase and acetylcholine in Soman poisoned rats. Drug Chem. Toxicol. 1 (1978) 355-362
173. Tajima T., Endo H., Suzuki Y., Ikari H., Gotoh M., and Iguchi A. Immobilization stress-induced increase of hippocampal acetylcholine and of plasma epinephrine, norepinephrine and glucose in rats. Brain Res. 720 (1996) 155-158
174. Tizabi Y., and Calogero A.E. Effect of various neurotransmitters and neuropeptides on the release of corticotropin-releasing hormone from the rat cortex in vitro. Synapse 10 (1992) 341-348
175. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
176. Tracey K.J., Czura C.J., and Ivanova S. Mind over immunity. FASEB J. 15 (2001) 1575-1576
177. + binding in cell surface associations. Protein Sci. 9 (2000) 180-185
178. van Haaren F., De Jongh R., Hoy J.B., Karlix J.L., Schmidt C.J., Tebbett I.R., and Wielbo D. The effects of acute and repeated pyridostigmine bromide administration on response acquisition with immediate and delayed reinforcement. Pharmacol. Biochem. Behav. 62 (1999) 389-394
179. Vereker E., O'Donnell E., and Lynch M.A. The inhibitory effect of interleukin-1 beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20 (2000) 6811-6819
180. Vyas A., Mitra R., Shankaranarayana Rao B.S., and Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 22 (2002) 6810-6818
181. Weeber E.J., Atkins C.M., Selcher J.C., Varga A.W., Mirnikjoo B., Paylor R., Leitges M., and Sweatt J.D. A role for the beta isoform of protein kinase C in fear conditioning. J. Neurosci. 20 (2000) 5906-5914
182. Weibel L., Follenius M., and Brandenberger G. Biologic rhythms: their changes in night-shift workers. Presse Med. 28 (1999) 252-258
183. Wilckens T., and De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol. Today 18 (1997) 418-424
184. Winslow J.T., and Camacho F. Cholinergic modulation of a decrement in social investigation following repeated contacts between mice. Psychopharmacology (Berl) 121 (1995) 164-172
185. Wolfe A.D., Blick D.W., Murphy M.R., Miller S.A., Gentry M.K., Hartgraves S.L., and Doctor B.P. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol. Appl. Pharmacol. 117 (1992) 189-193
186. Wolthuis O.L., Groen B., Busker R.W., and van Helden H.P. Effects of low doses of cholinesterase inhibitors on behavioral performance of robot-tested marmosets. Pharmacol. Biochem. Behav. 51 (1995) 443-456
187. Xie J., and Black D.L. A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels. Nature 410 (2001) 936-939
188. Xie J., and McCobb D.P. Control of alternative splicing of potassium channels by stress hormones. Science 280 (1998) 443-446
189. Xu L., Anwyl R., and Rowan M.J. Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature 387 (1997) 497-500
190. Yirmiya R., Pollak Y., Morag M., Reichenberg A., Barak O., Avitsur R., Shavit Y., Ovadia H., Weidenfeld J., Morag A., Newman M.E., and Pollmacher T. Illness, cytokines, and depression. Ann. N. Y. Acad. Sci. 917 (2000) 478-487
191. Zhou Z., Licklider L.J., Gygi S.P., and Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature 419 (2002) 182-185
192. Zigmond M.J. Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism. Neurobiol. Dis. 4 (1997) 247-253
193. Zoghbi H.Y. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 302 (2003) 826-830